| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a new hepatitis therapeutic agent. <P>SOLUTION: This hepatitis therapeutic agent containing the adipose tissue-originated interstitial cell group is completed by confirming that the group has high safety, the suppressing effect of necrosis of liver cells, and the improving effect of the hepatopathy marker value. <P>COPYRIGHT: (C)2012,JPO&INPIT</p> |
